Home > Boards > US Listed > Biotechs > Seres Therapeutics (MCRB)

Congrats for hitting your target. I'm thinking possible

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
frankvestor8 Member Profile
 
Followed By 0
Posts 80
Boards Moderated 0
Alias Born 06/29/16
160x600 placeholder
Seres Therapeutics Expands Executive Team with Appointments of David S. Ege, Ph.D., as Chief Technology Officer & Jayne M. Ga... Business Wire - 10/22/2020 7:00:00 AM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 10/21/2020 5:00:59 PM
Seres Therapeutics to Present SER-109 Phase 3 ECOSPOR III Study Results at American College of Gastroenterology Annual Scient... Business Wire - 10/12/2020 7:00:00 AM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 10/9/2020 2:17:46 PM
Seres Therapeutics to Present at the Jefferies Next Generation IBD Therapeutics Summit Business Wire - 9/22/2020 7:00:00 AM
Seres Therapeutics to Present at Upcoming Investor Conferences Business Wire - 9/14/2020 7:00:00 AM
Seres Therapeutics Announces U.S. Food and Drug Administration Correspondence Following Positive SER-109 Phase 3 Study Results Business Wire - 9/11/2020 7:00:00 AM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 9/10/2020 10:04:08 AM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 9/9/2020 6:05:05 AM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 9/8/2020 1:29:25 PM
Amended Statement of Beneficial Ownership (sc 13d/a) Edgar (US Regulatory) - 8/19/2020 5:18:18 PM
Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp) Edgar (US Regulatory) - 8/17/2020 4:22:24 PM
Seres Therapeutics, Inc. Announces Closing of Public Offerings of 12,075,000 Shares of Common Stock Business Wire - 8/17/2020 4:15:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/14/2020 5:10:13 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 8/14/2020 5:07:09 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 8/14/2020 5:04:39 PM
Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp) Edgar (US Regulatory) - 8/13/2020 6:06:59 AM
Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp) Edgar (US Regulatory) - 8/13/2020 6:01:38 AM
Seres Therapeutics, Inc. Announces Pricing of Public Offering of 10,500,000 Shares of Common Stock Business Wire - 8/12/2020 9:39:00 PM
Seres Therapeutics, Inc. Announces Proposed Public Offering of Common Stock Business Wire - 8/11/2020 5:48:00 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 8/11/2020 5:31:17 PM
Automatic Shelf Registration Statement of Securities of Well-known Seasoned Issuers (s-3asr) Edgar (US Regulatory) - 8/11/2020 5:12:12 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/10/2020 7:32:26 AM
Seres Therapeutics Announces Positive Topline Results from SER-109 Phase 3 ECOSPOR III Study in Recurrent C. difficile Infect... Business Wire - 8/10/2020 6:30:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 7/28/2020 10:02:53 AM
frankvestor8   Friday, 08/12/16 02:28:27 PM
Re: MARINO post# 121
Post # of 156 
Congrats for hitting your target. I'm thinking possible shorts when the rally runs out of steam. Too busy these days. Have yet to read its ER transcript. Have you listened to it or read it? What're the key things. Would be great to know before I find time to read it. Thanks.

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences